Should You Buy AbbVie Stock After The Recent 7% Fall?
- Tuesday, September 7, 2021, 7:19
- Market
- Add a comment
The stock price of AbbVie reached its 52-week high of around $121 just last week before a recent sell-off in ABBV stock, especially after the U.S. FDA stated that all janus kinase inhibitors approved for arthritis treatment should carry a heart-risk warning on the label – sending the stock to lower.
About the Author
admin123 has written 23446 stories on this site.
